Clinical Trials Browser

Phase 4 × atezolizumab × Gastrointestinal × Clear all

NCT05717400 2024-12-31

Improving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C Virus Infection With Direct-Acting Antiviral Therapy

Phase 4 Terminated

2 enrolled 8 charts

Gastrointestinal

Liver Neoplasms

NCT05185505 2023-02-01

Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria

Phase 4 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms